Why Omada’s CEO thinks Amazon selected his startup for its new program

The latest stories trending on MedCity News.

Editor's Pick

Top Story Why Omada's CEO Thinks Amazon Selected His Startup as the 1st Partner for Its New Program Amazon launched a new initiative to help connect people to digital health benefits that they may not know are available to them. Omada Health is its first partner. CEO Sean Duffy said his company stood out from the many other virtual diabetes care companies out there because about 20 million Americans — many of whom shop on Amazon — are eligible for Omada's programs. Sponsored Content The PBM Model of the Future: Why Payers Are Unbundling PBM Services Presented by MedCity News & Abarca Health Javier Gonzalez, Chief Growth and Commercial Officer at Abarca, about why payers are increasingly looking for alternatives to the traditional PBM model.  Learn More. Get Your Super Early Bird Pricing You still have time to secure your seat with our super early bird pricing ($995) on INVEST 2024. Connect with VCs, innovative startups, investors, and executives across healthcare for the best boutique networking event healthcare offers. Register Now

Featured News

What Was the Most-Repeated Word in CVS Health CEO's JPM Presentation? The word has gained greater urgency in recent years as the consumer trend in healthcare has forced payers, providers and all other kinds of healthcare stakeholders to swear by it. Uber Health, Socially Determined Strike Partnership Through a new partnership, payers and providers will be able to leverage Socially Determined's social risk data to identify which patients have barriers to accessing healthcare and what those barriers are. Uber Health will then be able to offer its services to support those patients' specific needs, whether it's non-emergency medical transportation, same-day prescription delivery or grocery and over-the-counter item delivery. Boston Scientific Continues Buying Spree with $3.7B Axonics Acquisition Medical device giant Boston Scientific added to its string of recent acquisitions by announcing its plan to buy Axonics, a maker of neurostimulation devices that treat urinary and bowel dysfunction, for $3.7 billion. Experts agree that this deal will make a profitable impact on Boston Scientific's urology business. Will We Close the Medicare Advantage Primary Care Gap in 2024? Medicare Advantage patients without a primary care physician are perhaps the greatest risk to health plans in 2024. Health plans must adopt best practices to reach and engage MA patients, especially those with multiple, complex conditions. Here are six best practices to consider. Medtronic CEO On the Company's AI: This Isn't About ChatGPT Geoff Martha sought to establish a clear line between popular understanding of AI created by apps like ChatGPT and what he believes is the significant impact that Medtronic's AI-enabled products are already having on patients and other healthcare stakeholders today. J&J Joins the Cancer ADC Dealmaking Spree With $2B Ambrx Acquisition Johnson & Johnson's acquisition of antibody drug conjugate developer Ambrx Biopharma comes as Novartis and Merck also unveiled M&A deals on the first day of the J.P. Morgan Healthcare conference. In a report, the investment bank said big pharmas are looking for deals involving de-risked assets. A Smoke Screen: Why Dying From Lung Cancer Isn't Inevitable It's high time we reframe how we think about lung cancer by ending the shame and judgment. I care less about if you quit smoking, I care more that you get screened. No one should have to die, period.

Resources

How To Enable a Hyperpersonal Care Experience This on-demand webinar features expert panelists from Praia Health and Providence, interviewed by AVIA to discuss the benefits of adopting a hyperpersonal care model for patients, barriers that hold health systems back, and will unpack Praia Health's technology capabilities. Watch Now

MedCity News • PO Box 901 • New York, NY unsubscribe